Evidence map›Paper›PMID 29467010›Full record

ArticleStem cell research & therapy2018

Human adipose-derived stem cells inhibit bioactivity of keloid fibroblasts.

Xiuxia Wang, Yan Ma, Zhen Gao, Jun Yang

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04391621 phase2unknown statusnot on this mapstarted 2021, after this paper: background citation

Efficacy of Autologous Adipose Derived Stromal Vascular Fraction in the Treatment of Keloids

TypeinterventionalSponsorMakerere UniversityRan2021 to 2023Enrolled30ConditionsAdipose Derived Stem Cells, KeloidArmsAutologous Adipose Derived stem cell transplantation, Triamcinolone Acetonide 40Mg/Ml Inj,Susp_#1
NCT04553159 phase2completednot on this mapstarted 2021, after this paper: background citation

Autologous Adipose Derived Stem Cell Transplantation in the Treatment of Keloids. A Pilot Randomized Controlled Trial

TypeinterventionalSponsorMakerere UniversityRan2021 to 2021Enrolled8ConditionsKeloid, Autologus Adipose Derived Stem Cells, Feasibility, SafetyArmsAutologous adipose derived stem cells
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Future Directions About Keloid Scars Based on Pathogenesis and Therapies.Clinical, cosmetic and investigational dermatology · 2024
    Review
  20. Fibrosis in burns: an overview of mechanisms and therapies.American journal of physiology. Cell physiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xiuxia WangDepartment of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhi Zao Ju Road, Shanghai, 200011, China.
Yan MaDivision of Plastic Surgery, Xinjiang Korla Bazhou People's Hospital, Xinjiang, China.
Zhen GaoDepartment of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhi Zao Ju Road, Shanghai, 200011, China. mucunaizhi@126.com.
Jun YangDepartment of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhi Zao Ju Road, Shanghai, 200011, China. shgaozhen_9h@yahoo.com.
Shanghai Jiao Tong University · CNBozhou People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA keloid is a fibroproliferative disorder occurring in wounds characterized by an exaggerated response to injury. To date, no effective cure has been identified. As multipotent stem cells, human adipose-derived stem cells (ADSCs) may show the possibility for curing diseases such as fibrosis. This study sought to explore the potential role of human ADSCs in curing keloids.

methodsAfter culture in conditioned medium, gene and protein expression of keloid fibroblasts was examined using real-time polymerase chain reaction (RT-PCR) and Western blotting, while analysis of the cell cycle was used to measure the proliferative properties of the cells. Furthermore, ex vivo explant cultures were used to test the effects of ADSC-conditioned medium (ADSC-CM) on CD31

resultsOur experimental results show that ADSC-CM was able to attenuate extracellular matrix-related gene expression as well as decrease protein expression. Cell proliferation was significantly suppressed in our study. CD31

conclusionsHuman ADSC-CM significantly inhibited keloid fibroblast-related bioactivities.

Indexed as

Gene Expression RegulationAdipose TissueCulture Media, ConditionedExtracellular MatrixFemaleFibroblastsHumansKeloidMaleStem CellsCulture Media, ConditionedAdipose-derived stem cellsConditioned mediumKeloid fibroblasts

Identifiers

PMID29467010
PMCPMC5822616
OpenAlexW2802732580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.